Cardiologists may be fleeing the practice of medicine over the next decade, according to one poll, and healthcare reform may be fueling the exodus. One looming challenge is pay-for-performance. Are you ready?

Agfa HealthCare has signed a seven-year contract extension with Shrewsbury and Telford Hospital National Health Services Trust in England for PACS and DR systems.

The top news of the week may seem all too familiar to radiology stakeholders. On the one hand is the bad news: Demand for radiologists has plummeted. The other hand shows the promise of diagnostic imaging. Studies have illustrated its potential to extend the golden window for stroke treatment, expedite evaluation and care of patients with chest pain and detect amyloid plaque. And in the middle is the drop in imaging utilization, which was attributed to a variety of factors.

When the Congressional Budget Office (CBO) released its analysis of the Supreme Courts ruling in the Patient Protection and Affordable Care Act (PPACA), many reports focused on the cost savings: $84 billion. Few pointed out the nuances within the 21-page document.

The marketing authorization from the European Commission has granted Boehringer Ingelheim and Eli Lilly regulatory approval of Jentadueto (linagliptin/metformin hydrochloride) tablets, a medicine combining the DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta tablets, marketed under the trade name Trajenta in Europe) and metformin in a single tablet taken twice daily.

The FDA has granted 510(k) clearance to the Corindus Vascular Robotics' CorPath 200 system to be used during PCI procedures.

Data analytics provider Atigeo has launched xPatterns Explorer into the U.S. National Institutes of Health's PubMed body of medical research.

White knights appear in many forms, but not often as a study in a medical journal. But the publication of a study this week in the Journal of the American Medical Association may be hailed for swooping in just in time to change the course of a public policy decision that, some neurologist say, would misalign incentives and ultimately harm patients if left as is.